A new AI model analyzes unlabeled brain MRIs to predict brain age, dementia risk, tumor mutations, and cancer survival, demonstrating strong performance even with limited training data.
AI tool predicts brain age, cancer survival and other disease signals from unlabeled brain MRIs
Mass General Brigham investigators have developed a robust new artificial intelligence (AI) foundation model that is capable of analyzing brain MRI datasets to perform numerous medical tasks, including identifying brain age, predicting dementia risk, detecting brain tumor mutations and predicting brain cancer survival.
